The Long Non Coding MALAT1 as a Potential Salivary Diagnosti... | Clinical Trial | StuddyBuddy@endsection
← Back to all trials
Completed
NCT05708209
The Long Non Coding MALAT1 as a Potential Salivary Diagnostic Biomarker in Oral Squamous Cell Carcinoma Through Targeting mi RNA 124
Conditions: Oral Cancer Biomarkers
Sex: All
Enrollment: 40
Sponsor: Fayoum University
Location: Egypt
Summary
Objective: is to determine the diagnostic accuracy of lncRNA MALAT1 as a potential salivary biomarker of OSCC as well as assessment of the salivary expression level of miRNA 124 which is targeted by MALAT1.
Materials and Methods: Saliva Samples were collected for the quantitative determination of salivary "MALAT1 and mi RNA -124" using quantitative Real-time Polymerase Chain Reaction technique for the two study groups, Group A: 20 patients with a diagnosis suggestive of OSCC and Group B: 20 age-and-sex-matched healthy individuals, as normal controls.
Eligibility Criteria
Inclusion Criteria:The study included patients with OSCC and healthy controls of both sexes.Exclusion Criteria:Patients having systemic diseases such as; liver diseases, cardiovascular disease, nervous system, pulmonary, renal, endocrine, gastrointestinal disorders, or other types of cancer were excluded.
Source: ClinicalTrials.gov (NCT05708209). StuddyBuddy aggregates publicly available trial information.